The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors.


Journal

Journal of clinical apheresis
ISSN: 1098-1101
Titre abrégé: J Clin Apher
Pays: United States
ID NLM: 8216305

Informations de publication

Date de publication:
Aug 2021
Historique:
revised: 17 04 2021
received: 23 03 2021
accepted: 19 04 2021
pubmed: 5 5 2021
medline: 27 1 2022
entrez: 4 5 2021
Statut: ppublish

Résumé

Adverse donor events (ADEs) are usually mild and short-term with no sequelae, but may cause disinclination toward future donations. To determine the impact of delayed ADEs (D-ADEs) in addition to immediate ADEs (I-ADEs) on the intention of future donations (IFDs) and to analyze the various associated factors. ADEs were categorized following the ISBT working group on donor vigilance. Telephonic interviews of the donors were conducted 2 weeks after the whole blood (WB) and plateletpheresis donation to inquire about D-ADEs and IFDs. A total of 3514 WB and 531 plateletpheresis donors were included in the study. WB donors had an overall higher IFD as compared to plateletpheresis donors (89.53% vs 57.06%, P < .001). A higher IFD was observed in male WB donors as compared to female WB donors (89.95% vs 75%, P < .001). Repeat WB donors had a higher IFD as compared with first-time donors (93.66% vs 81.37%, P < .001). A total of 13.7% WB donors and 19.2% plateletpheresis donors reported D-ADEs. WB donors who experienced D-ADEs had a significantly lower IFD (78.38% vs 91.63%, P < .001) as compared with donors without any ADEs; a similar trend was observed in donors who experienced I-ADEs (69.90% vs 91.63%, P < .001). In WB donors, systemic D-ADEs such as fatigue had a more negative impact on IFDs as compared with localized D-ADEs such as bruises (63.93% vs 86.83%, P < .001). Both D-ADEs and I-ADEs negatively impact donors' intention to donate again. Systemic D-ADEs had a more negative impact on IFDs as compared with localized D-ADEs.

Sections du résumé

BACKGROUND BACKGROUND
Adverse donor events (ADEs) are usually mild and short-term with no sequelae, but may cause disinclination toward future donations.
AIMS OBJECTIVE
To determine the impact of delayed ADEs (D-ADEs) in addition to immediate ADEs (I-ADEs) on the intention of future donations (IFDs) and to analyze the various associated factors.
METHODS METHODS
ADEs were categorized following the ISBT working group on donor vigilance. Telephonic interviews of the donors were conducted 2 weeks after the whole blood (WB) and plateletpheresis donation to inquire about D-ADEs and IFDs.
RESULTS RESULTS
A total of 3514 WB and 531 plateletpheresis donors were included in the study. WB donors had an overall higher IFD as compared to plateletpheresis donors (89.53% vs 57.06%, P < .001). A higher IFD was observed in male WB donors as compared to female WB donors (89.95% vs 75%, P < .001). Repeat WB donors had a higher IFD as compared with first-time donors (93.66% vs 81.37%, P < .001). A total of 13.7% WB donors and 19.2% plateletpheresis donors reported D-ADEs. WB donors who experienced D-ADEs had a significantly lower IFD (78.38% vs 91.63%, P < .001) as compared with donors without any ADEs; a similar trend was observed in donors who experienced I-ADEs (69.90% vs 91.63%, P < .001). In WB donors, systemic D-ADEs such as fatigue had a more negative impact on IFDs as compared with localized D-ADEs such as bruises (63.93% vs 86.83%, P < .001).
CONCLUSIONS CONCLUSIONS
Both D-ADEs and I-ADEs negatively impact donors' intention to donate again. Systemic D-ADEs had a more negative impact on IFDs as compared with localized D-ADEs.

Identifiants

pubmed: 33942928
doi: 10.1002/jca.21902
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-627

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Newman BH, Pichette S, Pichette D, Dzaka E. Adverse effects in blood donors after whole-blood donation: a study of 1000 blood donors interviewed 3 weeks after whole-blood donation. Transfusion. 2003;43(5):598-603.
Tiwari AK, Aggarwal G, Dara RC, Arora D, Srivastava K, Raina V. Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: first attempt in India. Transfus Apher Sci. 2017;56(2):141-146.
Schlumpf KS, Glynn SA, Schreiber GB, et al. National heart, lung, and blood institute retrovirus epidemiology donor study. Factors influencing donor return. Transfusion. 2008;48(2):264-272.
Newman BH, Newman DT, Ahmad R, Roth AJ. The effect of whole-blood donor adverse events on blood donor return rates. Transfusion. 2006;46(8):1374-1379.
Newman B. Arm complications after manual whole blood donation and their impact. Transfus Med Rev. 2013;27(2):44-49.
France CR, France JL, Roussos M, Ditto B. Mild reactions to blood donation predict a decreased likelihood of donor return. Transfus Apher Sci. 2004;30(1):17-22.
France CR, Rader A, Carlson B. Donors who react may not come back: analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions. Transfus Apher Sci. 2005;33(2):99-106.
Olatunji BO, Etzel EN, Ciesielski BG. Vasovagal syncope and blood donor return: a examination of the role of experience and affective expectancies. Behav Modif. 2010;34(2):164-174.
Veldhuizen I, Atsma F, van Dongen A, De Kort W. Adverse reactions, psychological factors, and their effect on donor retention in men and women. Transfusion. 2012;52(9):1871-1879.
Germain M, Glynn SA, Schreiber GB, et al. Determinants of return behavior: a comparison of current and lapsed donors. Transfusion. 2007;47(10):1862-1870.
Notari EP 4th, Zou S, Fang CT, Eder AF, Benjamin RJ, Dodd RY. Age-related donor return patterns among first-time blood donors in the United States. Transfusion. 2009;49(10):2229-2236.
Custer B, Rios JA, Schlumpf K, Kakaiya RM, Gottschall JL, Wright DJ. NHLBI retrovirus epidemiology donor study-II (REDS-II). Adverse reactions and other factors that impact subsequent blood donation visits. Transfusion. 2012;52(2):118-126.
Nguyen DD, Devita DA, Hirschler NV, Murphy EL. Blood donor satisfaction and intention of future donation. Transfusion. 2008;48(4):742-748.
Thomson RA, Bethel J, Lo AY, Ownby HE, Nass CC, Williams AE. Retention of “safe” blood donors. The retrovirus epidemiology donor study. Transfusion. 1998;38(4):359-367.
Standard for Surveillance of Complications Related to Blood Donation, ISBT; 2015. Available from http://www.isbtweb.org/fileadmin/user_upload/files-2015/haemovigilance/definitions/Standard%202008%20remark%20surveillance%20complications%20related%20to%20blood%20donation%20haemovigilance.pdf, Accessed March 22, 2021.
Gupta AM, Bajpai M. Delayed adverse reactions in whole blood donors: the importance of active surveillance in identifying the missing gaps in the donor safety. Indian J Med Res. (accepted).
Gupta AM, Bajpai M. Delayed adverse events in male plateletpheresis donors: initial insights on donor safety. J Clin Apher. 2020;35(1):18-24.
Bednall TC, Bove LL. Donating blood: a meta-analytic review of self-reported motivators and deterrents. Transfus Med Rev. 2011;25(4):317-334.
Öhrner C, Kvist M, Blom Wiberg K, Diedrich B. Why do young men lapse from blood donation? Vox Sang. 2019;114(6):566-575.
Sinclair KS, Campbell TS, Carey PM, Langevin E, Bowser B, France CR. An adapted post donation motivational interview enhances blood donor retention. Transfusion. 2010;50(8):1778-1786.

Auteurs

Abhaykumar Malind Gupta (AM)

Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.

Meenu Bajpai (M)

Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH